Please Wait.....
Report
Thin Film Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 130 Pages I Mordor Intelligence
Thin Film Drugs Market Analysis
The thin film drug market size reached USD 11.71 billion in 2025 and is forecast to touch USD 18.29 billion by 2030, advancing at a 9.32% CAGR. Demand growth stems from an aging global population, mounting dysphagia prevalence, and regulatory encouragement for patient-centric formulations. Manufacturers are capitalizing on superior adherence profiles, rapid onset of action, and the ability to tailor dose strengths for vulnerable groups. Investments in hot-melt extrusion and solvent-casting lines are lowering production costs, while microneedle innovations position the technology to address chronic disease management needs in outpatient settings. Competitive strategies emphasize partnerships between formulation specialists and large pharmaceutical companies to shorten development timelines and widen therapeutic scope.
Global Thin Film Drugs Market Trends and Insights
Rising Prevalence Of Dysphagia & Geriatric Population
Dysphagia affects 36.9% of nursing-home residents and 27% of older adults, creating a large cohort unable to swallow conventional tablets. Beyond age-related issues, neurological disorders and post-surgical complications amplify demand for alternate dosage forms. Health systems incur significant costs from aspiration pneumonia and non-adherence, prompting reimbursement support for film formulations. Pediatric use cases reinforce universal applicability, while community pharmacists using EAT-10 screening tools now flag swallowing issues earlier, broadening product access points.
Increasing Approvals & Investments In Thin-Film Therapeutics
RizaFilm's 2024 FDA clearance for migraine relief underlined the agency's confidence in thin film platforms. Aquestive's NDA for Anaphylm demonstrates how sublingual epinephrine could disrupt autoinjectors through needle-free delivery. Large companies channel new spending into U.S. manufacturing: Johnson & Johnson alone announced USD 55 billion for advanced dosage capabilities, signaling sustained capital flow toward film technologies. Clearer bioequivalence guidelines now reduce regulatory uncertainty, encouraging venture capital to back specialized developers.
Availability Of Substitute Dosage Forms (ODTs, Injectables)
Orally disintegrating tablets enjoy mature production lines and lower costs, curbing thin film uptake in price-sensitive categories. European Pharmacopoeia recognition of ODTs ensures streamlined approvals, while injectables remain dominant where precise pharmacokinetics matter, such as oncology. Established infrastructure and falling generic prices limit thin film pricing power when convenience alone is the differentiator.
Other drivers and restraints analyzed in the detailed report include:
Superior Patient Compliance Versus Conventional Dosage Forms / Opioid-Harm-Reduction Policies Accelerating Buccal Film Uptake / Moisture-Sensitivity Driving High-Cost Barrier Packaging /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Oral films captured 70.51% of thin film drug market share in 2024 thanks to straightforward regulatory paths and cost-effective solvent-casting lines. Transdermal formats post a 13.65% CAGR to 2030 as microneedle-integrated patches broaden drug classes deliverable through skin.
Manufacturers can scale oral films rapidly, leveraging hot-melt extrusion to incorporate poorly soluble APIs. Transdermal films require precise micro-fabrication and adhesive engineering, limiting large-scale output today. Nonetheless, vaccine delivery and hormone therapy trials are yielding positive acceptance data, indicating transdermal systems will narrow the gap during the forecast horizon.
Opioid use disorder dominated with 36.53% of thin film drug market size in 2024 because buprenorphine films align with government harm-reduction goals. Chronic pain films exhibit the fastest 11.85% CAGR as prescribers pivot to non-opioid molecules that benefit from rapid oromucosal absorption.
Migraine therapies gain traction after RizaFilm's clearance, enabling in-home treatment during nausea episodes. Sublingual immunotherapy films in allergy care and emergency systemic delivery for anaphylaxis show promise, diversifying the clinical portfolio. Collectively, these indications reinforce a broad therapeutic runway for the thin film drug market.
The Thin Film Drugs Market Report is Segmented by Product Type (Oral Thin Films [Orodispersible Films, and More], Transdermal Thin Films [Passive Patches, and More]), Indication (Schizophrenia, Migraine, and More), Distribution Channel (Hospital Pharmacies, and More), Drug Type (Prescription (Rx) and Over-The-Counter (OTC)), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
North America led with 41.32% share in 2024, supported by FDA guidance that clarifies bioequivalence and stability expectations. Robust insurance coverage and specialty pharmacy networks expedite market entry, while sizable investments in continuous manufacturing ensure domestic capacity for rapid scale-up.
Europe maintains second position through centralized approvals that streamline multi-country launches. Emphasis on patient safety and high adherence among seniors underpins demand. Regional CDMOs specialize in solvent-casting and HME, serving global supply chains.
Asia-Pacific posts 10.61% CAGR to 2030, propelled by regulatory harmonization and expanded manufacturing grants in China, India, and South Korea. Lower labor costs and government incentives attract technology-transfer deals, positioning the region as a production hub for global thin film drug market exports. Rising healthcare spending and urbanization open large patient pools receptive to convenient dosage forms.
List of Companies Covered in this Report:
Indivior / Aquestive Therapeutics / ZIM Laboratories / Kindeva / BioDelivery Sciences Intl. / Nualtis / Tesa SE (Tesa Labtec) / Pfizer / Novartis / Viatris / GlaxoSmithKline / Cure Pharmaceutical / ARx LLC / Solvay SA / Sumitomo Dainippon Pharma / 3D Matrix Ltd / MonoSol Rx / Catalent / Adhex Pharma / Tapemark LLC / Lohmann Therapie-Systeme /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence Of Dysphagia & Geriatric Population
4.2.2 Increasing Approvals & Investments In Thin-Film Therapeutics
4.2.3 Superior Patient Compliance Versus Conventional Dosage Forms
4.2.4 Opioid-Harm-Reduction Policies Accelerating Buccal Film Uptake
4.2.5 Hot-Melt-Extrusion HPMC Grades Enable Higher-Dose, Heat-Sensitive APIs
4.3 Market Restraints
4.3.1 Availability Of Substitute Dosage Forms (ODTs, Injectables)
4.3.2 Moisture-Sensitivity Driving High-Cost Barrier Packaging
4.3.3 Limited Solvent-Casting Capacity For High-Potency APIs
4.4 Technological Outlook
4.5 Porter's Five Forces
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitutes
4.5.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product Type
5.1.1 Oral Thin Films
5.1.1.1 Orodispersible Films
5.1.1.2 Sublingual Films
5.1.1.3 Buccal Films
5.1.2 Transdermal Thin Films
5.1.2.1 Passive Patches
5.1.2.2 Active / Microneedle-assisted Patches
5.2 By Indication
5.2.1 Schizophrenia
5.2.2 Migraine
5.2.3 Opioid Use Disorder
5.2.4 Nausea & Vomiting
5.2.5 Chronic Pain
5.2.6 Allergy & Asthma
5.3 By Distribution Channel
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Online Pharmacies
5.4 By Drug Type
5.4.1 Prescription (Rx)
5.4.2 Over-the-Counter (OTC)
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 South Korea
5.5.3.5 Australia
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Indivior PLC
6.3.2 Aquestive Therapeutics
6.3.3 ZIM Laboratories
6.3.4 Kindeva
6.3.5 BioDelivery Sciences Intl.
6.3.6 Nualtis
6.3.7 Tesa SE (Tesa Labtec)
6.3.8 Pfizer Inc.
6.3.9 Novartis AG
6.3.10 Viatris Inc
6.3.11 GSK plc
6.3.12 Cure Pharmaceutical
6.3.13 ARx LLC
6.3.14 Solvay SA
6.3.15 Sumitomo Dainippon Pharma
6.3.16 3D Matrix Ltd
6.3.17 MonoSol Rx / Catalent
6.3.18 Adhex Pharma
6.3.19 Tapemark LLC
6.3.20 Lohmann Therapie-Systeme
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security